Wockhardt Prepares USFDA Submission for Zaynich; 2026 Market Entry In Sight | Business News | ET Now　 #ETNOW

Dr. Habil Khorakiwala of Wockhardt Group announced imminent USFDA filing for Zaynich, targeting Q2 FY26 approval and 2026-27 launch. Confident due to recent USFDA talks; plans US manufacturing to dodge tariffs. MICMAF eyes ₹100+ crore sales next year. Global gram-negative infection market: $9B opportunity.

#wockhardt #zaynich #usfda #pharmanews #antiinfectives #micmaf #gramnegative #druglaunch #tariffstrategy #biotech #etnow

control your money with economic times now.

YouTube Channel – https://www.youtube.com/@ETNow

Subscribe To ET Now For Latest Updates On Stocks Market News , Business News, Company News, IPO & More | https://bit.ly/SubscribeToETNow

Subscribe Now To Our Network Channels :-
ET Now Swadesh: https://www.youtube.com/etnowswadesh
Times Now: http://goo.gl/U9ibPb

Social Media Links :-
Twitter – http://goo.gl/hA0vDt
Facebook – http://goo.gl/5Lr4mC

Website – https://ift.tt/glWDAiu